Cancer Family
Head and Neck Neoplasm
CI-CAN-00000021Explore in graph →
Non-malignant1,571 active trials17 approved drugs142 evidence items
Loading cancer entity…
Cancer Family
CI-CAN-00000021Explore in graph →
Clinical trials
6,372 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01739634 | The Efficacy of CASAD in Patients With Diarrhea Related to Medullary Thyroid Cancer | unknown | Phase 1 / Phase 2 | 10 | Salient Pharmaceuticals IncorporatedINDUSTRY | 1 | Dec 3, 2012 | clinicaltrials |
| NCT01697891 | A Pilot Study of ALTENS in Improving Dysphagia Induced by IMRT for Head and Neck Cancers | unknown | Phase 1 / Phase 2 | 35 | McMaster UniversityOTHER | 1 | Oct 2, 2012 | clinicaltrials |
| NCT01655628 | GC Regimen Chemotherapy Plus CIK Cells for Metastatic Nasopharyngeal Carcinoma | unknown | Phase 2 | 40 | Sun Yat-sen UniversityOTHER | 1 | Aug 2, 2012 | clinicaltrials |
| NCT01614938 | Induction Chemotherapy Followed by Concurrent Radiation With Cetuximab or Cisplatin in Locally Advanced Nasopharyngeal Cancer | unknown | Phase 2 | 46 | Fudan UniversityOTHER | 1 | Jun 8, 2012 | clinicaltrials |
| NCT00774319 | TPF Induction With Concomitant Chemoradiation to Treat Patients With Head and Neck Cancer(Condor) | unknown | Phase 2 | 70 | Radboud University Medical CenterOTHER | 1 | Apr 11, 2012 | clinicaltrials |
| NCT00982436 | Neoadjuvant Cisplatin/Docetaxel (CDDP/TXT) and Chemoradiation for Head and Neck Cancer | unknown | Phase 1 / Phase 2 | 37 | University of VermontOTHER | 1 | Mar 22, 2012 | clinicaltrials |
| NCT01516996 | Safety and Efficacy Study of Nimotuzumab Plus Neoadjuvant and Concurrent Chemoradiotherapy to Treat Oropharynx and Hypopharynx Cancer | unknown | Phase 2 | 80 | The Second People's Hospital of SichuanOTHER | 1 | Mar 20, 2012 | clinicaltrials |
| NCT01472653 | Treatment Selection According to Skin Reaction to Cetuximab | unknown | Phase 2 | 120 | Institute of Oncology LjubljanaOTHER | 1 | Dec 13, 2011 | clinicaltrials |
| NCT00855881 | Metronomic Chemotherapy With Tegafur/Uracil for Head and Neck Squamous Cell Carcinoma | unknown | Phase 2 | 115 | Mackay Memorial HospitalOTHER | 1 | Jul 26, 2011 | clinicaltrials |
| NCT01086488 | Foscan®-Mediated Photodynamic Therapy Versus Brachytherapy in Patients With Nasopharyngeal Carcinoma(FOSCAN) | unknown | Phase 2 | 66 | Ministry of Health, MalaysiaOTHER_GOV | 1 | Jul 8, 2011 | clinicaltrials |
| NCT01377298 | Pazopanib in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma | unknown | Phase 2 | 45 | National Taiwan University HospitalOTHER | 1 | Jun 21, 2011 | clinicaltrials |
| NCT01301248 | Cisplatin Chemoradiation With or Without Cetuximab for Locoregionally Advanced Squamous Cell Carcinomas (SCC) of the Head and Neck | unknown | Phase 2 | 80 | Theagenio Cancer HospitalOTHER_GOV | 1 | May 17, 2011 | clinicaltrials |
| NCT01312311 | Weekly Docetaxel Plus Cisplatin as the First-line Therapy for Nasopharyngeal Cancer | unknown | Phase 2 | 51 | Samsung Medical CenterOTHER | 1 | Mar 10, 2011 | clinicaltrials |
| NCT01291095 | Accelerated Fractionation Radiotherapy (AFRT) Versus Concurrent Chemoradiotherapy (Crt) In Locally Advanced Head And Neck Squamous Cell Carcinoma | unknown | Phase 2 | 80 | All India Institute of Medical SciencesOTHER | 1 | Mar 4, 2011 | clinicaltrials |
| NCT00625937 | Docetaxel and S-1 Followed By Radiation Therapy and Low-Dose Cisplatin in Treating Patients With Stage III or Stage IV Head and Neck Cancer | unknown | Phase 2 | 46 | Yonsei UniversityOTHER | 1 | Feb 28, 2011 | clinicaltrials |
| NCT00786552 | Pemetrexed + Paclitaxel in Patients With Recurrent/Advanced Thyroid Cancer(Panthera) | unknown | Phase 2 | 47 | University Hospital Schleswig-HolsteinOTHER | 1 | Jan 20, 2011 | clinicaltrials |
| NCT01265147 | Intensity-modulated Radiation Therapy Combined With Cisplatin or Nedaplatin Chemotherapy in Nasopharyngeal Carcinoma | unknown | Phase 2 | 20 | Daping Hospital and the Research Institute of Surgery of the Third Military Medical UniversityOTHER | 1 | Jan 20, 2011 | clinicaltrials |
| NCT00357617 | Celecoxib in Treating Patients With Head and Neck Cancer That Can Be Removed By Surgery | unknown | Phase 1 / Phase 2 | 24 | Centre Hospitalier Universitaire VaudoisOTHER | 1 | Dec 24, 2010 | clinicaltrials |
| NCT01260480 | An Efficacy and Safety Study to Assess [18F]-ML-10 in Detecting Response of Tumors to Chemotherapy and Radiation | unknown | Phase 2 | 60 | Aposense Ltd.INDUSTRY | 1 | Dec 17, 2010 | clinicaltrials |
| NCT00363831 | Combination of Capecitabine and Oxaliplatin in Metastatic Nasopharyngeal Carcinoma | unknown | Phase 2 | 42 | The University of Hong KongOTHER | 1 | Jul 28, 2010 | clinicaltrials |
| NCT00634595 | Trial of E10A in Head and Neck Cancer | unknown | Phase 2 | 116 | Sun Yat-sen UniversityOTHER | 1 | Jul 28, 2010 | clinicaltrials |
| NCT01073683 | Induction Docetaxel/Cisplatin/5-fluorouracil (TPF) as Selector for Chemo Radiation Therapy (RT) Versus Partial Laryngectomy in Advanced Laryngeal Cancer | unknown | Phase 2 | 100 | Rabin Medical CenterOTHER | 1 | Mar 5, 2010 | clinicaltrials |
| NCT00948337 | A Study With Health Educational Material on Health Promotion in Cancer Survivors | unknown | Phase 2 | 326 | National Cancer Center, KoreaOTHER_GOV | 1 | Feb 26, 2010 | clinicaltrials |
| NCT00690872 | Gemcitabine and Carboplatin Followed By Laboratory-Treated T Lymphocytes in Treating Patients With Metastatic or Locally Recurrent Epstein-Barr Virus-Positive Nasopharyngeal Cancer | unknown | Phase 2 | 35 | National Cancer Centre, SingaporeOTHER | 1 | Jun 29, 2009 | clinicaltrials |
| NCT00004164 | Combination Chemotherapy in Treating Patients With Stage IIB, Stage III, or Stage IV Cancer of the Nasopharynx | unknown | Phase 2 | — | Dana-Farber Cancer InstituteOTHER | 1 | Feb 9, 2009 | clinicaltrials |
| NCT00817583 | Induction Chemotherapy Followed by Concurrent Chemoradiotherapy for Nasopharyngeal Carcinoma (NPC)(TPF for NPC) | unknown | Phase 2 | 100 | Fudan UniversityOTHER | 1 | Jan 27, 2009 | clinicaltrials |
| NCT00817258 | Study of Concurrent Chemotherapy and Radiotherapy for Stage II Nasopharyngeal Carcinoma | unknown | Phase 2 | 37 | Fudan UniversityOTHER | 1 | Jan 6, 2009 | clinicaltrials |
| NCT00816816 | Phase Ⅱ Study of Neoadjuvant Chemotherapy Followed by Concurrent Chemoradiation for Stage ⅣAB Nasopharyngeal Carcinoma | unknown | Phase 2 | 64 | Fudan UniversityOTHER | 1 | Jan 5, 2009 | clinicaltrials |
| NCT00816855 | Phase Ⅱ Study of Neoadjuvant Chemotherapy Followed by Concurrent Chemoradiation for Stage Ⅲ Nasopharyngeal Carcinoma | unknown | Phase 2 | 52 | Fudan UniversityOTHER | 1 | Jan 5, 2009 | clinicaltrials |
| NCT00003327 | Paclitaxel in Treating Patients With Recurrent or Refractory Head and Neck Cancer | unknown | Phase 2 | 60 | TheradexINDUSTRY | 1 | Jul 24, 2008 | clinicaltrials |
| NCT00652613 | Study of 3-Dimensional Conformal Radiotherapy (3D-CRT) Versus Intensity Modulated Radiotherapy (IMRT) for Head and Neck Squamous Cell Carcinoma (HNSCC) | unknown | Phase 2 | 60 | Tata Memorial HospitalOTHER_GOV | 1 | Apr 11, 2008 | clinicaltrials |
| NCT00180921 | Study of Imatinib (Glivec) in Patients With Adenoid Cystic Carcinoma of the Head and Neck | unknown | Phase 2 | 30 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Sep 26, 2007 | clinicaltrials |
| NCT00251381 | Cetuximab & Concomitant-Boost Accelerated RT in Patients With Locally Advanced Oropharynx Squamous Cell Carcinoma. | unknown | Phase 2 | 90 | Trial Form Support S.L.OTHER | 1 | Oct 26, 2006 | clinicaltrials |
Data updated 22 days agoSource updated Dec 3, 2012source: clinicaltrials